The use of tolterodine in children after oxybutynin failure-Reference-Cited by-同舟云学术

The use of tolterodine in children after oxybutynin failure

Published:2003-03 Issue:4 Volume:91 Page:398-401
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Bolduc S.,Upadhyay J.,Payton J.,Bägli D.J.,McLorie G.A.,Khoury A.E.,Farhat W.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410X.2003.04085.x/fullpdf

Reference22 articles.

1. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability;Yarker;Drugs Aging,1995

2. Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity;Brynne;Int J Clin Pharmacol Ther,1997

3. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder;Abrams;Br J Urol,1998

4. Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study;Rentzhog;Br J Urol,1998

5. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity;Millard;J Urol,1999

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost analysis for mirabegron use in the treatment of children with neurogenic bladder;Journal of Pediatric Urology;2023-10

2. Updates of Overactive Bladder in Pediatrics;International Neurourology Journal;2023-03-31

3. Daytime Urinary Incontinence;Pediatric Surgery;2023

4. Comprehensive Review of Nocturnal Enuresis in Children;Journal of Pediatrics Review;2022-07-01

5. Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children;Expert Opinion on Pharmacotherapy;2022-05-06